NCT04910165View on ClinicalTrials.gov

Exparel Use in Adductor Canal Block After Total Knee Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

September 15, 2021

Study Completion Date

October 15, 2021

Conditions
Arthritis KneePain, PostoperativeOpioid Use
Interventions
DRUG

Exparel

Exparel used in Adductor Canal Block plus Infiltration Between Popliteal Artery and Capsule of Knee using Ropivacaine

DRUG

Ropivacaine

Ropivacaine used in Adductor Canal Block plus Infiltration Between Popliteal Artery and Capsule of Knee using Ropivacaine

Trial Locations (1)

18015

St. Luke's University Health Network, Bethlehem

All Listed Sponsors
lead

St. Luke's Hospital, Pennsylvania

OTHER

NCT04910165 - Exparel Use in Adductor Canal Block After Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter